Prophylactic heparin does not prevent liver veno‐occlusive disease following autologous bone marrow transplantation

European Journal of Haematology - Tập 47 Số 5 - Trang 346-354 - 1991
L. Marsa‐Vila1, Norbert Claude Gorin1, J.P. Laporte1, Myriam Labopin1, M. C. Dupuy‐Montbrun1, L Fouillard1, F Isnard1, A Najman1
1Hopital Saint Antoine, Department of Hematology, Bone Marrow Transplant Unit, Formation associée Claude Bernard “Unité de recherche sur les greffes de cellules souches hematopoietiques”, and Centre National de Transfusion Sanguine (CNTS), Paris, France

Tóm tắt

Abstract: Veno‐occlusive disease (VOD) is a major cause of toxic death after autologous bone marrow transplantation (ABMT). We studied the potential role of continuous administration of low‐dose heparin for VOD prevention in 234 consecutive patients who underwent ABMT in our institution. The population consisted of 98 patients autografted before October 1984 who did not receive heparin, and a series of 136 patients autografted from October 1984 to March 1989 containing 98 patients included in a randomized trial comparing heparin administration (n = 52) vs no heparin (n = 46), and an additional group of 38 patients who received non‐randomized heparin in view of high‐risk criteria to develop VOD (n = 31) or other reasons unrelated to VOD (n = 7). Overall, 90 patients (38%) received heparin and 144 (62%) did not. The global incidence of VOD was 13/234 (5–5%). Heparin did not reduce the risk of VOD in all subgroups studied. In particular, in the randomized trial, the incidence of VOD was 2.2% in the group without heparin vs 7–7% in the group receiving heparin. We analyzed in depth the 13 patients who developed VOD and we compared them to a control group of 13 patients pair‐matched for age, sex, diagnosis and preparative regimen, who did not develop VOD. We found that abnormal LFT before ABMT predisposed patients to VOD; refractoriness to platelet transfusion was observed in 85% of the patients in the VOD group vs 15% in the control group (p<0.05). VOD patients had an increased requirement for red cells and platelet transfusions, a lower recovery (R<25%) after the second and third platelet transfusion, and shorter intervals separating the first four platelet transfusions. Further, the platelet reconstitution after ABMT in the VOD group was slower in comparison to the control group (p<0.01). Again, in this pair‐matched analysis continuous infusion of low‐dose heparin did not prevent VOD.

Từ khóa


Tài liệu tham khảo

10.1002/hep.1840040121

McDonald GB, 1982, Venocclusive disease of the liver after marrow transplantation. Clinical course of 53 patients, Gastroenterology, 82, 1237

Gorin NC, 1981, High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors. A study of 23 patients, Eur J Cancer Clin Oncol, 17, 557

10.1016/S0308-2261(86)80004-2

10.1182/blood.V67.5.1367.1367

Nadler SB, 1962, Prediction of blood volume in normal human adults, Surgery, 51, 224

10.1182/blood.V67.6.1773.1773

Kalbfleish LS, 1980, The statistical analysis of failure time data

10.1200/JCO.1983.1.7.440

10.1200/JCO.1989.7.4.515

Gorin NC, 1989, Autologous bone marrow transplants: different indications in Europe and North America, Lancet, 317

10.1200/JCO.1988.6.10.1562

Bras G., 1954, Veno‐occlusive disease of the liver with non‐portal type of cirrhosis, occurring in Jamaica, Arch Pathol, 57, 285

Brooks SEH, 1970, Acute veno‐occlusive disease of the liver. Fine Structure in Jamaican children, Arch Pathol, 89, 507

10.1136/pgmj.54.634.511

10.1136/adc.32.165.369

10.1136/gut.26.1.101

Safouh M., 1965, Hepatic vein occlusion disease in Egyptian children, Arch Pathol, 79, 505

10.1016/S0016-5085(19)32224-3

Goodman ZD, 1982, Occlusive venous lesions in alcoholic liver disease. A study of 200 cases, Gastroenterol, 83, 786, 10.1016/S0016-5085(82)80007-3

10.1016/S0046-8177(76)80082-2

Fajardo LF, 1980, Pathogenesis of veno‐occlusive liver disease after radiation, Arch Pathol Lab Med, 104, 584

Ingold JA, 1965, Radiation hepatitis, Am J Roentgenol Radium Ther Nucl Med, 93, 200

Reed GB, 1966, The human liver radiation injury. A form of veno‐occlusive disease, Am J Pathol, 48, 597

10.1001/archsurg.1968.01330240024006

Lewin K., 1973, Human radiation hepatitis. A morphologic study with emphasis on the late changes, Arch Pathol, 96, 21

10.1056/NEJM195012212432502

10.1093/ajcp/22.1.22

Marubbio AT, 1975, Hepatic veno‐occlusive disease in a renal transplant patient receiving azathioprine, Gastroenterology, 69, 739, 10.1016/S0016-5085(19)32476-X

10.1016/0002-9343(61)90186-3

10.1007/BF00429351

10.1136/jcp.35.10.1086

10.7326/0003-4819-104-5-651

10.1007/BF01299927

10.7326/0003-4819-96-1-58

10.1159/000199104

10.1002/1097-0142(19800515)45:10<2670::AID-CNCR2820451031>3.0.CO;2-L

10.1002/1097-0142(19831115)52:10<1803::AID-CNCR2820521007>3.0.CO;2-D

10.7326/0003-4819-85-5-578

10.7326/0003-4819-87-2-247_2

Brugieres L., 1988, Complications hépatiques après chimiothérapie lourde et autogreffe de moelle dans les tumeurs solides de l'enfant, Press Méd, 17, 1305

Cahn JY, 1985, Fréquence des maladies veino‐occlusives du foie après greffe de moelle osseuse, Presse Méd, 14, 1520

10.1016/S0046-8177(82)80008-7

10.1097/00007890-198712000-00011

10.1002/1097-0142(19820501)49:9<1789::AID-CNCR2820490910>3.0.CO;2-H

10.1097/00007890-198506000-00005

10.1016/0016-5085(86)90949-2

10.1016/0016-5085(80)90911-7

10.1093/ajcp/75.4.614

Dulley FL, 1987, Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation, Transplantation, 43, 870, 10.1097/00007890-198706000-00020

10.2214/ajr.150.2.289

10.1002/1097-0142(19900801)66:3<515::AID-CNCR2820660319>3.0.CO;2-7

10.1097/00004836-198210000-00011

Shulman HM, 1987, Hepatic veno‐occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules, Am J Pathol, 127, 549

10.1016/0002-9343(86)90266-4

Rowland FN, 1984, Fibrin‐mediated vascular injury. Identification of fibrin peptides that mediate endothelial cell retraction, Am J Pathol, 117, 418

Devergie A., 1986, Changes in endothelial and coagulation parameters after allogeneic bone marrow transplantation (BMT) as a mean of prediction of veino‐occlusive disease (VOD), Exp Hematol, 14, 430

Scrobohaci ML, 1988, Les tests d'hémostase marqueurs de la toxicité hépatique et endothéliale des chimiothérapies, Nouv Rev Franç Hemat, 30, 109

Eder JP, 1985, Changes in von Willebrand's factor (vWF) in high dose chemotherapy, Proc Am Soc Clin Oncol, 4, 268

10.1002/1097-0142(19890215)63:4<643::AID-CNCR2820630407>3.0.CO;2-J

10.1182/blood.V75.4.1011.1011

Saint‐Marc G., 1985, Veno‐occlusive disease after bone marrow transplantation. Prevalence, prognosis, and predisposing factors. An experience based on 127 transplant patients, Hepatology, 5, 993

Baume D., 1987, Maladie veino‐occlusive du foie après greffe de moelle osseuse. Intérêt du fractionnement de l'irradiation totale, Press Méd, 16, 1759

Rio B., 1984, Fréquence et gravité des maladies veino‐occlusives du foie après greffe de moelle osseuse, Presse Méd, 13, 2648

10.1136/gut.23.6.465

10.7326/0003-4819-90-2-158

10.1007/978-3-642-74643-7_120

10.1097/00007890-198907000-00016

10.1016/0002-9343(80)90368-X

Cahn JY, 1985, Maladie veino‐occlusive du foie et autogreffe de moelle osseuse, Rôle préventif de l'héparine? Nouv Rev Fr Hematol, 27, 27

10.1002/1097-0142(197901)43:1<174::AID-CNCR2820430126>3.0.CO;2-Q

Bearman SI, 1990, A pilot study of continuous infusion heparin for the prevention of hepatic veno‐occlusive disease after bone marrow transplantation, Bone Marrow Transplant, 5, 407

10.1182/blood.V57.3.395.bloodjournal573395

10.1097/00007890-198804000-00036

10.1055/s-2007-1003534

Thông tin
Thông tin xuất bản

European Journal of Haematology

Tập 47 Số 5

346-354

Thông tin tác giả